|Videos|September 29, 2020

Common skin conditions in pediatric skin of color patients

In part two of our interview with Candrice Heath, M.D., she explains the most commonly encountered skin conditions when treating young skin of color patients.

Part 1: Tips and tricks for treating young skin of color patients

Listen to the full interview with Candrice Heath, M.D., here.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe

Related Content

Mind the Gap: Will Digital Replace Clinical?

ByCandice Fortunato, MD

September 4th 2026

Individualizing Sun-Safety Counseling: Matching Patient Goals With Cancer Risk

ByJoshua Arbesman, MD,Marie Bosslett, Assistant Editor

September 4th 2026

AbbVie Completes $10.9 Billion Apogee Acquisition, Adds Zumilokibart to AD Pipeline

ByShannon Heaning, Content Associate

September 3rd 2026

Joshua Arbesman, MD, on Balancing Photoprotection and Quality of Life in Melanoma Counseling

ByJoshua Arbesman, MD,Marie Bosslett, Assistant Editor

September 3rd 2026

The Evolving CSU Pipeline: Biologics, BTK Inhibitors, and Biomarker-Guided Care

ByNicholas Brownstone, MD,Marie Bosslett, Assistant Editor

September 2nd 2026

Latest CME

Video

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Hadar Lev-Tov, MD; Martina Porter, MD

Video

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Common skin conditions in pediatric skin of color patients

Related Content

Mind the Gap: Will Digital Replace Clinical?

Individualizing Sun-Safety Counseling: Matching Patient Goals With Cancer Risk

AbbVie Completes $10.9 Billion Apogee Acquisition, Adds Zumilokibart to AD Pipeline

Joshua Arbesman, MD, on Balancing Photoprotection and Quality of Life in Melanoma Counseling

The Evolving CSU Pipeline: Biologics, BTK Inhibitors, and Biomarker-Guided Care

Latest CME

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Trending on Dermatology Times

AbbVie Completes $10.9 Billion Apogee Acquisition, Adds Zumilokibart to AD Pipeline

Journal Digest: September 2, 2026

Uncovering the Autoimmune Links & Systemic Impact of Chronic Spontaneous Urticaria

Dermatology Times Launches Derm Nexus Congress for NPs and PAs

Dermatology Times Conferences & Meetings Calendar: September 2026